The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - BeiGene; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Merck; MSD; Roche; Sanofi
Ezabenlimab (BI 754091) plus modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) followed by chemoradiotherapy (CRT) in patients (pts) with stage III squamous cell anal carcinoma (SCCA): Early efficacy endpoint results from the phase II INTERACT-ION study.
 
Stefano Kim
Honoraria - Amgen; Merck Serono; MSD; Pfizer; SERVIER
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer; Sanofi
 
Jihane Boustani
Research Funding - Boehringer Ingelheim France (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology
 
Dewi Vernerey
Consulting or Advisory Role - AC BioScience; Apmonia Therapeutics; cellprothera; CURE51; Fondazione Smith Kline; GERCOR; HalioDx; INCYTE; INVECTYS; Janssen-Cilag; OSE Immunotherapeutics; Pfizer; Veracyte
Travel, Accommodations, Expenses - MSD
 
Ludovic Evesque
Honoraria - AstraZeneca; SERVIER
 
Benoist Chibaudel
No Relationships to Disclose
 
Angélique Vienot
No Relationships to Disclose
 
Olivier Bouche
Consulting or Advisory Role - Amgen; Apmonia Therapeutics; Bayer; Deciphera; MSD Oncology; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; Servier
Travel, Accommodations, Expenses - MSD Oncology; Servier
 
Chloé Vernet
No Relationships to Disclose
 
Clélia Coutzac
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Merck Serono; MSD Oncology; SERVIER
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; SERVIER
Speakers' Bureau - Amgen; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Mundipharma; Sandoz; SERVIER
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Sanofi
 
Laurent Quero
Honoraria - IPSEN; Merck (Inst); Sanofi/Aventis
Research Funding - AstraZeneca (Inst)
 
Laurent Mineur
Speakers' Bureau - Bayer
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Merck Serono
 
Aurelién Carnot
Speakers' Bureau - Astellas Pharma; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Amgen
 
Aurelia Meurisse
No Relationships to Disclose
 
Magali Rebucci-Peixoto
No Relationships to Disclose
 
Sarah Chennoufi
Employment - Boehringer Ingelheim
 
Christophe Maritaz
Employment - Boehringer Ingelheim France
Travel, Accommodations, Expenses - Boehringer Ingelheim France
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)